Medtronic (MDT) Tops Q2 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $94.17 +1.15%
Revenue Growth %: +5.3%
Financial Fact:
Diluted earnings per share: 0.98
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.3%
Financial Fact:
Diluted earnings per share: 0.98
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q2 EPS of $1.36, $0.05 better than the analyst estimate of $1.31. Revenue for the quarter came in at $9 billion versus the consensus estimate of $8.87 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.62-$5.66, versus the consensus of $5.62.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- Morgan Stanley Downgrades Sims Metal Management Ltd. (SGM:AU) (SMUPF) to Underweight
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
